HomeNewsWorldFive things we still don't know about the coronavirus

Five things we still don't know about the coronavirus

One of the biggest mysteries is why the virus produces few or no symptoms in around 80 percent of people, according to the World Health Organization, yet in others it can lead to fatal pneumonia.

April 01, 2020 / 08:43 IST

Despite extensive study by doctors and scientists across the world since the new coronavirus first appeared in China three months ago, much about the scourge is still unclear. Here are five key questions that remain unanswered about the virus officially known as SARS-CoV-2 that leads to COVID-19.

One of the biggest mysteries is why the virus produces few or no symptoms in around 80 percent of people, according to the World Health Organization, yet in others it can lead to fatal pneumonia.

"Findings from February indicated that the clinical spectrum of this disease can be very heterogeneous," said Professor Leo Poon from the School of Public Health at Hong Kong University.

During the peak of the epidemic in China, he and a team from the University of Nanchang compared those with mild and severe forms of the illness.

Their study, published in the British journal The Lancet, found that those hardest hit were "significantly older" and that the concentration of the virus in the nose and throat was around 60 times higher than those lightly affected.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The question remains whether this result can be explained by the subjects' less reactive immune systems because of their age or whether they were simply more exposed to the virus.

Research on the measles virus has shown that the gravity of the illness is related to the level of exposure. Experts do not yet know whether this is the same for COVID-19.

Coronavirus is known to spread through physical contact and through droplets dispersed when an infected person coughs or sneezes.

But can it also hang in the air like the virus that causes the seasonal flu? One US study published in the New England Journal of Medicine shows that the new coronavirus can survive in air particles in a laboratory for three hours.

But scientists do not know if the disease can still be transmitted at that stage.

"We don't know if the virus can hang around for a long time in the air or on inert surfaces," Professor Karine Lacombe, head of infectious diseases at Saint Antoine Hospital in Paris, told AFP.

"We know we can find the virus, but we do not know if the virus is infectious."

Apart from the few countries that have used aggressive testing, like South Korea and Germany, global figures on the number of people carrying the virus are sketchy.

The British government estimated that on March 17, 55,000 people there had the virus when less than 2,000 had officially tested positive.

A precise understanding of the spread of the epidemic is vital to isolating and treating those infected as well as developing a profile of those who can build up immunity to it.

This will be possible once a new generation of blood tests are developed that are capable of tracing the immune reaction to SARS-CoV-2.

Will COVID-19 be halted with the arrival of warm spring and summer weather in the northern hemisphere? Experts say this is possible, but not certain.

Respiratory viruses like the flu are more stable in cold and dry weather, which is why they spread more rapidly in winter.

Hong Kong researchers found that the SARS virus of 2002-03 in Asia -- closely related to the new coronavirus -- survived best when humidity and temperatures were low.

But a recent study by the Harvard Medical School in the United States warned that "changes in weather alone (with an increase of temperature and humidity as spring and summer months arrive in the northern hemisphere) will not necessarily lead to declines in COVID-19 cases without the implementation of extensive public health interventions."

Children have been relatively spared by COVID-19 than adults, and those infected have been less sick.

Chinese research published in the review Nature showed that none of the 10 children with COVID-19 that they followed became terribly ill, with symptoms limited to sore throats, a cough and a mild fever.

Researchers also found that children living with people sick with the virus were two to three times less likely to catch it than adults.

The same was true of the SARS virus in 2002-03.

"There are lots of things that we do not know, which should lead us to approach this with a lot of humility," warned Professor Lacombe.

PTI
first published: Apr 1, 2020 08:35 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347